Loncastuximab tesirine in patients with B-cell non-Hodgkin lymphoma
Kahl, B.S.
Clinical Advances in Hematology and Oncology H&o 16(11): 732-734
2018
ISSN/ISBN: 1543-0790 PMID: 30543588 Document Number: 695578
Document emailed within 1 workday
Related Documents
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Blend, M.J.; Hyun, H.; Kozloff, M.; Levi, H.; Mills, G.Q.; Gasparini, M.; Buraggi, G.; Hughes, L.; Pinsky, C.M.; Goldenberg, D.M. 1995: Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragment Cancer Research 55(23 Suppl): 5764s-5770s
Tachi, T.; Yasuda, M.; Usui, K.; Umeda, M.; Nagaya, K.; Osawa, T.; Ichihashi, A.; Noguchi, Y.; Goto, H.; Kasahara, S.; Takahashi, T.; Goto, C.; Teramachi, H. 2015: Risk factors for developing infusion reaction after rituximab administration in patients with B-cell non-Hodgkin's lymphoma Die Pharmazie 70(10): 674-677
Hołowiecki, J.; Giebel, S.; Walewski, J.; Krawczyk-Kuliś, M.łg.; Hellmann, A.; Skotnicki, A.; Dmoszyńska, A.; Romejko, J.; Czyz, J.ła.; Jurczak, W.; Kachel, Łu.; Wojnar, J.; Stella-Hołowiecka, B.; Saduś-Wojciechowska, M.; Sułek, K.; Jedrzejczak, W.ła.; Robak, T.; Mariańska, B.; Szczylik, C.; Warzocha, K. 2003: Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. the experience of Polish lymphoma research group Polskie Archiwum Medycyny Wewnetrznej 110(2): 863-868
Mitarnun, W.; Pradutkanchana, J.; Takao, S.; Saechan, V.; Suwiwat, S.; Ishida, T. 2002: Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis Journal of the Medical Association of Thailand 85(5): 552-559
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Gaudin, P.; Rozand, Y.; Fauconnier, J.; Phelip, X. 1995: Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients Revue du Rhumatisme 62(5): 365-375
Chubachi, A.; Miura, A.B.; Takatsu, H.; Yamaguchi, A.; Nishimura, S.; Nakayama, Y.; Akihama, T.; Miura, S.; Saitoh, M.; Watanuki, T. 1991: Clinical significance of immunophenotype in diffuse non-Hodgkin's lymphoma: with special emphasis on the clinical characteristics of T-cell lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(8): 1303-1309
Somers, R.; van Heerde, P. 1983: Non-Hodgkin lymphoma in patients with Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 127(2): 55-59
Yurchenko, M.; Sidorenko, S.P. 2010: Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate Experimental Oncology 32(4): 214-223
Acabá, L.; Santiago, N.; Vélez García, E. 1996: T-cell rich B-cell lymphoma masquerading as Hodgkin disease: excellent outcome to inadequate therapy Boletin de la Asociacion Medica de Puerto Rico 88(4-6): 32-34
Li, C.C.; O'Connell, C.D.; Beckwith, M.; Longo, D.L. 1995: Detection of p53 mutations in B cell non-Hodgkin's lymphoma cell lines Leukemia 9(4): 650-655
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Marafioti, T.; Mancini, C.; Ascani, S.; Sabattini, E.; Zinzani, P.Luigi.; Pozzobon, M.; Pulford, K.; Falini, B.; Jaffe, E.S.; Müller-Hermelink, H-Konrad.; Mason, D.Y.; Pileri, S.A. 2004: Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease Haematologica 89(8): 957-964
2014: Safety and efficacy of brentuximab vedotin (SGN-35) in Hodgkin lymphoma patients undergoing reduced intensity allogeneic stem cell transplant following a relapse after autologous transplant Clinical Advances in Hematology and Oncology: H&o 12(8 Suppl. 16): 20
Romano, M.; Libshitz, H.I. 1998: Hodgkin disease and non-Hodgkin lymphoma: plain chest radiographs and chest computed tomography of thoracic involvement in previously untreated patients La Radiologia Medica 95(1-2): 49-53
Anania, G.; Baccarani, U.; Risaliti, A.; Terrosu, G.; Donini, A.; Mariuzzi, L.; Bresadola, F. 1997: Primary non-Hodgkin's T-cell lymphoma of the breast European Journal of Surgery 163(8): 633-635
Visser, O.J.; Zijlstra, J.M.; van Dongen, G.A.M.S.; Huijgens, P.C. 2005: Radio-immunotherapy for B-cell non-Hodgkin lymphoma Nederlands Tijdschrift Voor Geneeskunde 149(42): 2324-2328